On 27 September 2018, FEAM European Biomedical Policy Forum organised a round table discussion on Companion diagnostics and precision medicine: regulatory and uptake barriers to patient access.
The round table was chaired by Professor Peter Meier-Abt, Vice-President of the Swiss Academy of Medical Sciences (SAMS) and chair of the National Steering Board of the Swiss Personalized Health Network, and by Professor Stefan Constantinescu, FEAM Vice-President and member of the Belgian and Romanian Academies of Medicine.
The aim of the round table was to:
The round table brought together representatives from the diverse sectors within the biomedical community (academia, industry, research organisations, patients, healthcare professionals) and policy-makers to discuss key policy issues related to this topic.
Presentation “CDx in oncology”, Prof. Christophe Le Tourneau (Curie Institute, Paris)
Presentation “CDx in other therapeutic areas”, Dr. Thorsten Gutjahr (AstraZeneca)
Presentation “Physicians’ perspective”, Dr. Daniel Widmer (UEMO)
The FEAM European Biomedical Policy Forum provides a platform for discussion on key policy issues for the biomedical community.
The Forum is an initiative from the Federation of European Academies of Medicine (FEAM). It aims to bring together representatives from academia, research charities, industry, European and national trade associations and professional bodies, regulators, public health bodies, and patient and consumers groups. If you would like further information on the FEAM European Biomedical Policy Forum or becoming a partner, please contact elisa.corritore@feam.eu.
